Literature DB >> 8099604

HLA class II susceptibility and resistance genes in patients with multiple sclerosis from northern Spain, by DNA-RFLP genotyping.

D F Uría, V Gutierrez, B B Menes, J M Arribas, C Lopez-Larrea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8099604      PMCID： PMC489634          DOI： 10.1136/jnnp.56.6.722

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  DNA analysis of HLA-DR4B1 subtypes in multiple sclerosis by specific oligonucleotide probes.

Authors:  M Victoria-Gutierrez; E Martinez-Naves; E Coto; O Dominguez; F Uría; J M Urra; C López-Larrea
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

2.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.

Authors:  O Olerup; J Hillert; S Fredrikson; T Olsson; S Kam-Hansen; E Möller; B Carlsson; J Wallin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 3.  DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens.

Authors:  J Bidwell
Journal:  Immunol Today       Date:  1988-01

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Multiple sclerosis and HLA class II susceptibility and resistance genes.

Authors:  D G Haegert; M Michaud; C Schwab; G S Francis
Journal:  J Neurosci Res       Date:  1990-05       Impact factor: 4.164
  5 in total
  3 in total

1.  Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.

Authors:  P A Muraro; M Vergelli; M Kalbus; D E Banks; J W Nagle; L R Tranquill; G T Nepom; W E Biddison; H F McFarland; R Martin
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

2.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

3.  Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice.

Authors:  Jacqueline A Quandt; Mirza Baig; Karen Yao; Kazuyuki Kawamura; Jaebong Huh; Samuel K Ludwin; Hong-Jin Bian; Mark Bryant; Laura Quigley; Zoltan A Nagy; Henry F McFarland; Paolo A Muraro; Roland Martin; Kouichi Ito
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.